#USA #Raleigh #LabConnect #CRO #Raleigh-Durham

LabConnect Establishes a New Global Headquarters in Raleigh-Durham

LabConnect, a prominent name in central laboratory solutions, recently announced the launch of its new global headquarters in the bustling Raleigh-Durham area. This decision marks a significant milestone for the company, as it positions itself in one of the leading hubs for contract research organizations (CROs), biotechnology firms, and pharmaceutical companies in the United States, known as the Research Triangle.

The establishment of this headquarters aims to bolster LabConnect's operations as it supports an expanding portfolio of complex clinical trials across the globe. The Raleigh-Durham region boasts a vibrant life sciences ecosystem, driven by its renowned research universities and a skilled workforce, along with a dense network of CROs. With this corporate office, LabConnect aims to strengthen collaboration with sponsors and partners, accelerating innovation in central laboratory services and creating enhanced opportunities for advanced sample management solutions and data integration technologies directly for its customers.

Wes Wheeler, the CEO of LabConnect, commented on the strategic importance of the new location: "With this new office in Raleigh, we find ourselves right where our clients make some of their most crucial decisions regarding drug development. RDU has become one of the world's key pharmaceutical innovation centers, and establishing a more robust corporate presence here enables us to collaborate even more closely with our clients, attract exceptional talent, and help speed the development of new medicines for those who need them."

The Raleigh office will complement LabConnect's seven operational locations globally, which already serve regions in North America, Latin America, Europe, the United Kingdom, Australia, China, and South Korea. By situating their operational facilities alongside their partner laboratories, LabConnect can better align its scientific, operational, and data capabilities with the needs of emerging and large-scale biopharmaceutical clients.

In forthcoming years, LabConnect intends to expand its Raleigh office further by adding leadership roles in commercial development, project management, scientific operations, technology, and data science. This investment reflects the company’s commitment to creating a modern, collaborative work environment that harnesses the strengths of the RDU market, while maintaining its low-resource global operational model and a flexible network of partner laboratories.

About LabConnect

LabConnect is reshaping the central laboratory services landscape by functioning as a technological partner for pharmaceutical and biotechnology companies. Its decentralized network model provides sponsors with the industry's most comprehensive global menu of testing, backed by advanced sample tracking, data management, and specialized consulting services. With a resource-efficient approach that encompasses functional solutions for service providers, specialized testing, and ancillary support, LabConnect achieves scalability and efficiency that transcend conventional laboratory ownership models. By building the laboratory network of the future, LabConnect accelerates the development of transformative therapies with greater precision, flexibility, and speed. For more information, follow them on LinkedIn or visit www.labconnect.com.